Key points:

• First experience with the new provisions and facilities for veterinary pharmacovigilance under the new regulation highlights advantages of the new signal management options not yet applied by smaller companies
• Basic pharmacovigilance processes can be managed without problems under the new data collection and management systems. However, for a number of specific cases, improvements are being sought

To read more key points and the session summary, log in as a member or register for free using the links below.